Akzo Nobel Toekomstige groei
Future criteriumcontroles 1/6
Akzo Nobel zal naar verwachting groeien in winst en omzet met respectievelijk 9% en 2.1% per jaar. De winst per aandeel zal naar verwachting groeien met 9.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 15.4% zijn.
Belangrijke informatie
9.0%
Groei van de winst
9.20%
Groei van de winst per aandeel
| Chemicals winstgroei | 15.6% |
| Inkomstengroei | 2.1% |
| Toekomstig rendement op eigen vermogen | 15.41% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 06 Aug 2026 |
Recente toekomstige groei-updates
Recent updates
Narratiefupdate • Jul 15
AKZA: Merger Execution And Russia Asset Seizure Will Shape Fairly Valued Shares
The updated analyst price target for Akzo Nobel moves from €61.71 to €63.71, with analysts pointing to adjustments in fair value estimates, discount rate assumptions, revenue growth expectations, profit margin forecasts, and future P/E inputs as reflected in recent research. Analyst Commentary Recent research on Akzo Nobel reflects a mix of optimism and caution, with analysts adjusting price targets and ratings as they reassess fair value, execution risks, and the company’s merger plans.
Narratiefupdate • Jun 30
AKZA: Merger With Axalta And Mixed Views Will Shape Next Phase
Akzo Nobel’s analyst price target has been lifted from about €49.30 to €55.00. Analysts cited updated revenue growth and margin assumptions, along with recent Street targets in the €55 to €61 range, as support for the higher fair value estimate.Narratiefupdate • Jun 16
AKZA: Merger Execution And Downgrade Reset Will Shape Fairly Valued Shares
Akzo Nobel's analyst price target has inched up to about €61.70 from roughly €61.18, as analysts factor in slightly higher fair value estimates and updated assumptions for discount rate, revenue growth and P/E. This follows mixed recent research that includes a resumed Buy rating and several price target cuts and downgrades.Narratiefupdate • Jun 02
AKZA: Margin Delivery And Downgrade Reset Will Shape Fairly Valued Repricing
Akzo Nobel's analyst price target has been cut by around €1 to €61, as analysts factor in more cautious assumptions on revenue growth and profitability following recent target reductions and downgrades from several major banks. Analyst Commentary Recent Street research on Akzo Nobel clusters around a series of target cuts and rating downgrades, with most analysts reworking their valuation frameworks to reflect more cautious assumptions on revenue growth and profitability.Narratiefupdate • May 02
AKZA: Margin Execution Is Expected To Support Repricing After Recent Downgrades
Akzo Nobel's updated analyst price target edges lower to about €62.60, as analysts factor in Street target cuts and downgrades, a slightly higher discount rate, and a more conservative future P/E assumption, despite using stronger revenue growth and profit margin inputs. Analyst Commentary Recent Street research on Akzo Nobel has focused on resetting expectations, with several firms lowering price targets and issuing downgrades.Narratiefupdate • Apr 17
AKZA: Margin Delivery Is Expected To Support Repricing After Recent Downgrades
Akzo Nobel's analyst price target has been trimmed by about €1.35. This reflects analysts' updated assumptions for slightly softer revenue growth and valuation multiples, partly balanced by a small uplift in expected profit margins.
Nieuw narratief • Apr 16
Merger Synergies And Cost Programs Will Create A More Powerful Coatings Leader
Catalysts About Akzo Nobel Akzo Nobel is a global paints and coatings company serving decorative, industrial, automotive, marine, aerospace and packaging customers. What are the underlying business or industry changes driving this perspective?Narratiefupdate • Apr 03
AKZA: Rebased Earnings And Margins Are Expected To Support Upside Repricing
Akzo Nobel's analyst fair value estimate has been trimmed by €2 to €65, as analysts factor in a series of recent downgrades and lower price targets, along with updated assumptions for growth, margins and future P/E levels. Analyst Commentary Recent Street research on Akzo Nobel presents a mix of cautious and constructive views, with several downgrades and price target cuts offset by at least one upward adjustment to fair value.Nieuw narratief • Apr 02
Cost Synergies And Portfolio Pruning Will Shape A Steady Long Term Coatings Platform
Catalysts About Akzo Nobel Akzo Nobel is a global paints and coatings company supplying decorative paints and performance coatings to customers across construction, industrial and transportation end markets. What are the underlying business or industry changes driving this perspective?Narratiefupdate • Mar 20
AKZA: Rebased Earnings Assumptions Will Support Upside Repricing Potential
Akzo Nobel's updated analyst price target has shifted modestly to €67.00, as analysts factor in a slightly higher discount rate, more conservative revenue growth and profit margin assumptions, and recalibrated P/E expectations despite mixed recent research views on the stock. Analyst Commentary Recent research on Akzo Nobel reflects a mix of optimism around upside potential and caution around execution risk, which together help explain the updated €67.00 price target.Analyse-artikel • Feb 15
We Think You Should Be Aware Of Some Concerning Factors In Akzo Nobel's (AMS:AKZA) Earnings
Akzo Nobel N.V.'s ( AMS:AKZA ) healthy profit numbers didn't contain any surprises for investors. We believe that...Narratiefupdate • Feb 05
AKZA: Axalta Merger Will Expand Scale And Recast Earnings Potential
Narrative Update The analyst price target for Akzo Nobel is updated to €68.12 from €69.65, reflecting mixed research views. Some analysts cite more measured expectations around the Axalta merger, muted coatings growth and a modest synergy timeline, while others maintain higher targets closer to €75 supported by their own assessments.Narratiefupdate • Jan 18
AKZA: Axalta Merger Will Reshape Scale And Earnings Profile
Analysts have nudged their fair value estimate for Akzo Nobel to €69.65 from €68.94, reflecting updated assumptions around revenue growth, margins and the Axalta merger, which align with recent Street price target moves between €59 and €75. Analyst Commentary Recent Street research around Akzo Nobel and its merger with Axalta provides a mixed but useful set of signals to consider when thinking about valuation, execution risk and growth potential.Analyse-artikel • Jan 12
Akzo Nobel (AMS:AKZA) Could Be At Risk Of Shrinking As A Company
When researching a stock for investment, what can tell us that the company is in decline? When we see a declining...Analyse-artikel • Dec 05
Is Akzo Nobel (AMS:AKZA) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analyse-artikel • Oct 22
Why Investors Shouldn't Be Surprised By Akzo Nobel N.V.'s (AMS:AKZA) P/E
With a price-to-earnings (or "P/E") ratio of 25.2x Akzo Nobel N.V. ( AMS:AKZA ) may be sending bearish signals at the...Analyse-artikel • Oct 09
Are Investors Undervaluing Akzo Nobel N.V. (AMS:AKZA) By 43%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Akzo Nobel fair value estimate is €105 Akzo Nobel's €59.94...Analyse-artikel • Aug 31
Is Akzo Nobel (AMS:AKZA) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyse-artikel • Aug 18
Is Now An Opportune Moment To Examine Akzo Nobel N.V. (AMS:AKZA)?
ENXTAM:AKZA 1 Year Share Price vs Fair Value Explore Akzo Nobel's Fair Values from the Community and select yours Let's...
Nieuw narratief • Nov 19
Steady Streamlining And Strategic Expansion Ignite A Brighter Future
Efficiency programs and workforce reductions are set to bolster net margins through significant cost savings.Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2028 | 10,520 | 744 | 636 | 1,089 | 15 |
| 12/31/2027 | 10,286 | 682 | 551 | 1,044 | 16 |
| 12/31/2026 | 10,041 | 540 | 362 | 933 | 15 |
| 6/30/2026 | 9,894 | 638 | 591 | 877 | N/A |
| 3/31/2026 | 9,931 | 622 | 645 | 941 | N/A |
| 12/31/2025 | 10,158 | 636 | 605 | 914 | N/A |
| 9/30/2025 | 10,405 | 59 | 526 | 849 | N/A |
| 6/30/2025 | 10,526 | 415 | 478 | 812 | N/A |
| 3/31/2025 | 10,684 | 467 | 392 | 728 | N/A |
| 12/31/2024 | 10,711 | 542 | 362 | 668 | N/A |
| 9/30/2024 | 10,621 | 565 | 536 | 842 | N/A |
| 6/30/2024 | 10,694 | 592 | 561 | 844 | N/A |
| 3/31/2024 | 10,651 | 534 | 733 | 998 | N/A |
| 12/31/2023 | 10,668 | 447 | 834 | 1,120 | N/A |
| 9/30/2023 | 10,745 | 411 | 572 | 840 | N/A |
| 6/30/2023 | 10,866 | 309 | 375 | 661 | N/A |
| 3/31/2023 | 10,978 | 303 | 8 | 305 | N/A |
| 12/31/2022 | 10,846 | 362 | -38 | 254 | N/A |
| 9/30/2022 | 10,643 | 540 | -155 | 140 | N/A |
| 6/30/2022 | 10,191 | 616 | 20 | 313 | N/A |
| 3/31/2022 | 9,849 | 758 | 245 | 533 | N/A |
| 12/31/2021 | 9,587 | 823 | 316 | 604 | N/A |
| 9/30/2021 | 9,393 | 805 | 750 | 1,041 | N/A |
| 6/30/2021 | 9,259 | 866 | 922 | 1,207 | N/A |
| 3/31/2021 | 8,735 | 741 | 1,078 | 1,347 | N/A |
| 12/31/2020 | 8,530 | 637 | 959 | 1,217 | N/A |
| 9/30/2020 | 8,563 | 544 | 817 | 1,052 | N/A |
| 6/30/2020 | 8,685 | 481 | 681 | 904 | N/A |
| 3/31/2020 | 9,149 | 567 | N/A | 747 | N/A |
| 12/31/2019 | 9,276 | 517 | N/A | 23 | N/A |
| 9/30/2019 | 9,342 | 477 | N/A | 210 | N/A |
| 6/30/2019 | 9,270 | 463 | N/A | 220 | N/A |
| 3/31/2019 | 9,265 | 354 | N/A | 84 | N/A |
| 12/31/2018 | 9,256 | 400 | N/A | 513 | N/A |
| 9/30/2018 | 9,231 | 393 | N/A | 652 | N/A |
| 6/30/2018 | 9,324 | 365 | N/A | 671 | N/A |
| 3/31/2018 | 9,411 | 426 | N/A | 882 | N/A |
| 12/31/2017 | 9,612 | 439 | N/A | 969 | N/A |
| 9/30/2017 | 6,022 | 107 | N/A | 772 | N/A |
| 6/30/2017 | 7,203 | 272 | N/A | 1,035 | N/A |
| 3/31/2017 | 8,381 | 417 | N/A | 1,261 | N/A |
| 12/31/2016 | 9,434 | 534 | N/A | 1,291 | N/A |
| 9/30/2016 | 14,300 | 1,032 | N/A | 1,477 | N/A |
| 6/30/2016 | 14,460 | 1,031 | N/A | 1,460 | N/A |
| 3/31/2016 | 14,698 | 1,051 | N/A | 1,414 | N/A |
| 12/31/2015 | 14,859 | 973 | N/A | 1,130 | N/A |
| 9/30/2015 | 14,817 | 772 | N/A | 784 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei AKZA ( 9% per jaar) ligt boven de spaarquote ( 2.3% ).
Winst versus markt: De winst van AKZA ( 9% per jaar) zal naar verwachting langzamer groeien dan de markt Dutch ( 17.3% per jaar).
Hoge groeiwinsten: De winst van AKZA zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van AKZA ( 2.1% per jaar) zal naar verwachting langzamer groeien dan de markt Dutch ( 10.9% per jaar).
Hoge groei-inkomsten: De omzet van AKZA ( 2.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen AKZA zal naar verwachting over 3 jaar laag zijn ( 15.4 %).
Ontdek groeibedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/08/10 10:10 |
| Aandelenkoers aan het einde van de dag | 2026/08/10 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Akzo Nobel N.V. wordt gevolgd door 42 analisten. 16 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Katie Richards | Barclays |
| Jennifer Barker | Barclays |
| Robert Bate | Barclays |